[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100464365":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":26,"centralContacts":30,"locations":35,"responsibleParty":50,"collaborators":25,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":56,"acronym":25,"eligibilityCriteria":57,"healthyVolunteers":54,"sex":58,"minAge":59,"maxAge":25,"enrollmentInfo":60,"targetDuration":25,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":25,"overallStatus":37,"whyStopped":25,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Kuopio University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Real tACS","EXPERIMENTAL","Four sessions (once a day, during four consecutive days) of gamma tACS (40 Hz) at 3 mA over the superior parietal cortex (Precuneus)",[13],"Device: Gamma tACS (40 Hz) over the superior parietal cortex",{"label":15,"type":16,"description":17,"interventionNames":18},"Sham tACS","PLACEBO_COMPARATOR","Four sessions of sham tACS (once a day, during four consecutive days) over the superior parietal cortex (Precuneus)",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","Gamma tACS (40 Hz) over the superior parietal cortex","Single session of gamma tACS (40 Hz) over the superior parietal cortex",[9,15],null,[27],{"name":28,"affiliation":5,"role":29},"Eino Solje, MD, PhD","PRINCIPAL_INVESTIGATOR",[31],{"name":28,"role":32,"phone":33,"phoneExt":25,"email":34},"CONTACT","+358 17 713 311","eino.solje@uef.fi",[36],{"facility":5,"status":37,"city":38,"state":25,"zip":25,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","Kuopio","Finland","FI",{"type":42,"coordinates":43},"Point",[44,45],27.67703,62.89238,{"lat":45,"lon":44},[48],{"name":49,"role":32,"phone":25,"phoneExt":25,"email":25},"Eino Solje",{"type":29,"investigatorFullName":49,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"MD PhD adj. prof.","100464365","non-invasive-neurostimulation-as-a-tool-for-diagnostics-and-management-for-neurodegenerative-diseases-100464365",false,"NCT05326750","Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases","Inclusion Criteria:\n\n* Mild Cognitive Impairment due to Alzheimer's disease\n* Dementia with Lewy Bodies\n* Frontotemporal dementia\n* Idiopathic normal pressure hydrocephalus (iNPH)\n\nExclusion Criteria:\n\n* History of seizures\n* Pregnancy\n* Metal implants in the head (except dental fillings)\n* Electronic implants (i.e. pace-maker, implanted medical pump)\n* Age \\\u003C18 years","ALL","18 Years",{"count":61,"type":62},200,"ESTIMATED","INTERVENTIONAL",[65],"NA","Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.",[68,69,70],"Alzheimer Disease","Frontotemporal Dementia","Dementia With Lewy Bodies","2025-08-26",{"date":73,"type":74},"2025-09-03","ACTUAL",{"date":76,"type":74},"2022-11-21",{"date":78,"type":62},"2032-07",{"name":5,"class":6},1]